Ann: WHA Finalises Supply Agreement with ISDC, page-34

First 34 Last

Share
Profile

Follow
Cosmoterios

4,813 Posts.

799

20/03/19

21:28

Post #: 37830592
Share

Originally posted by Cosmoterios: ↑

rzantika,

All the contrarian posters today have made very good points. Its exactly what the market has picked up (IMHO). These market players (institutions) have many analysts to go through every statement with a fine tooth comb. They are the ones who influenced the market today, not myself or any contrarian posters today.

Have a look at the number of people who agreed with such contrarian viewpoints (you will be lucky to find 5 who would agree). Those 5 individuals can not influence the market.

Any way, he made very valid points and they are:

1. Previously WHA have never made overseas sales of a few million dollars a year, now they are suggesting you will be achieving $100M in 42 months?

2. Previously WHA have not being able to sell their products to China at a profit - in fact, not even meeting costs after 2 years, but all of sudden they are telling you they can sell at almost $20 a tin. That does not make sense and the market has picked it up (whether you like it or not).

At the moment, it sound too good to be true. Its the reason I asked the question above, trying to find clarity. I am suggesting its not true, but I think the company need to clarify this issue, before confidence return, and finally

3. Previously - in quarterly and half yearly reports, they announced they were moving away from traditional to organic and will change their SAMR application from Traditional to Organic. Like myself, I think the market is looking for clarification on this issue as well: Is WHA now going back to Traditional SAMR accreditation or will WHA apply for two SAMR accreditations - one for traditional and one for Organic.

IMHO, with clarity, confidence should return.

Expand

Typo error:

"At the moment, it sound too good to be true. Its the reason I asked the question above, trying to find clarity. I am NOT suggesting its not true, but I think the company need to clarify this issue, before confidence return, and finally"

WHA Price at posting: 83.0¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

There are more pages in this discussion • 6 more messages in this thread...

First 34 Last

Add WHA (ASX) to my watchlist

Ann: WHA Finalises Supply Agreement with ISDC, page-34

Top Stories

Chimeric clocks $4.17M R&D tax rebate from Canberra

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals